The IL13α 2R paves the way for anti-glioma nanotherapy

The IL13α 2R paves the way for anti-glioma nanotherapy

Glioblastoma (GBM) is one of the most aggressive (grade IV) gliomas characterized by a high rate of recurrence, resistance to therapy and a grim survival prognosis. The long-awaited improvement in GBM patients’ survival rates essentially depends on advances in the development of new therapeutic appr...

Full description

Bibliographic Details
Main Authors: Ilya V. Ulasov, Anton Borovjagin, Anastasia Laevskaya, Margarita Kamynina, Peter Timashev, Laura Cerchia, Elena A. Rozhkova
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2023-01-01
Series:Genes and Diseases
Subjects:
Brain tumor
Experimental therapy
GBM
IL-13Rα2
Nanoparticles
Receptor
Online Access:http://www.sciencedirect.com/science/article/pii/S2352304221001033

Internet

http://www.sciencedirect.com/science/article/pii/S2352304221001033

Similar Items